El-Shamy A - Search Results

1

NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients.

El-Shamy A, Shoji I, El-Akel W, Bilasy SE, Deng L, El-Raziky M, Jiang DP, Esmat G, Hotta H. El-Shamy A, et al. J Clin Microbiol. 2012 Dec;50(12):3886-92. doi: 10.1128/JCM.02109-12. Epub 2012 Sep 19. J Clin Microbiol. 2012. PMID: 22993188 Free PMC article.

2

Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera.

El-Shamy A, Sasayama M, Nagano-Fujii M, Sasase N, Imoto S, Kim SR, Hotta H. El-Shamy A, et al. Microbiol Immunol. 2007;51(4):471-82. doi: 10.1111/j.1348-0421.2007.tb03922.x. Microbiol Immunol. 2007. PMID: 17446688 Free article.

3

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy.

El-Shamy A, Nagano-Fujii M, Sasase N, Imoto S, Kim SR, Hotta H. El-Shamy A, et al. Hepatology. 2008 Jul;48(1):38-47. doi: 10.1002/hep.22339. Hepatology. 2008. PMID: 18537193

4

Outcome and early viral dynamics with viral mutation in PEG-IFN/RBV therapy for chronic hepatitis in patients with high viral loads of serum HCV RNA genotype 1b.

Sasase N, Kim SR, Kudo M, Kim KI, Taniguchi M, Imoto S, Mita K, Hayashi Y, Shoji I, El-Shamy A, Hotta H. Sasase N, et al. Intervirology. 2010;53(1):49-54. doi: 10.1159/000252784. Epub 2010 Jan 5. Intervirology. 2010. PMID: 20068341

5

Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy.

El-Shamy A, Kim SR, Ide YH, Sasase N, Imoto S, Deng L, Shoji I, Hotta H. El-Shamy A, et al. Intervirology. 2012;55(1):1-11. doi: 10.1159/000322219. Epub 2011 Feb 4. Intervirology. 2012. PMID: 21293098

6

Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy.

El-Shamy A, Shoji I, Saito T, Watanabe H, Ide YH, Deng L, Kawata S, Hotta H. El-Shamy A, et al. Microbiol Immunol. 2011 Jun;55(6):418-26. doi: 10.1111/j.1348-0421.2011.00331.x. Microbiol Immunol. 2011. PMID: 21371092 Free article.

7

Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy.

El-Shamy A, Shoji I, Kim SR, Ide Y, Imoto S, Deng L, Yoon S, Fujisawa T, Tani S, Yano Y, Seo Y, Azuma T, Hotta H. El-Shamy A, et al. PLoS One. 2012;7(2):e30513. doi: 10.1371/journal.pone.0030513. Epub 2012 Feb 2. PLoS One. 2012. PMID: 22319571 Free PMC article.

8

Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load.

Kim SR, El-Shamy A, Imoto S, Kim KI, Ide YH, Deng L, Shoji I, Tanaka Y, Hasegawa Y, Ota M, Hotta H. Kim SR, et al. J Gastroenterol. 2012 Oct;47(10):1143-51. doi: 10.1007/s00535-012-0578-z. Epub 2012 Mar 24. J Gastroenterol. 2012. PMID: 22441534

9

Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.

El-Shamy A, Shindo M, Shoji I, Deng L, Okuno T, Hotta H. El-Shamy A, et al. Hepatology. 2013 Aug;58(2):555-63. doi: 10.1002/hep.26205. Epub 2013 Jun 14. Hepatology. 2013. PMID: 23281009

10

Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.

El-Shamy A, Hotta H. El-Shamy A, et al. World J Gastroenterol. 2014 Jun 28;20(24):7555-69. doi: 10.3748/wjg.v20.i24.7555. World J Gastroenterol. 2014. PMID: 24976696 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters